|
 |
Cardiac Studies
2009 PI - Leslie Klaff, MD, Ph D (Phase II)
A Phase II Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Evaulation of the Efficacy and Safety of An Investigational Medication by High Resolution Magnetic Resonance Imaging (MRI) in Carotid Atherosclerotic Plaque
2009 PI - Leslie Klaff, MD, Ph D (Phase III)
A Clinical Outcomes Study of An Investigational Medication Versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
2008 PI – Terrance A. Block, MD (Phase III)
A Phase 3, Randomized, Double Blind, Double Dummy, Parallel Group, Multicenter, Multinational Study for Evaluation of Efficacy and Safety of An Investigational Medication Versus Warfarin In Subjects with Atrial Fibrillation – Effective aNticoaGulation with factor xA next Generation in Atrial Fibrillation (ENGAGE-AF)
1998 PI - Terrance Block, MD
A Phase II Double-blind, Placebo-Controlled, Randomized Efficacy Study of an Investigational Medication in Patients Undergoing Direct Percutaneous Transluminar Coronary Angioplasty Following Acute Myocardial Infarction
1997 PI - Allen Sussman, MD
A Multicenter, Double-blind, Placebo Controlled, Parallel Group Study to Evaluate the Safety , Tolerability and Efficacy of an Investigational Medication for Four Weeks in Out-Patients with Chronic Obstructive Pulmonary Disease.
1995-1996 PI - Terence Block, MD
A Study to Determine the Efficacy and Safety of an Investigational Medication in Non- Q-Wave Coronary Events: A Double-blind, Randomized, Parallel Group, Multicenter Study Comparing an Investigational Medication and Intravenous Unfractionated Heparin |
Phase I & Pharmacokinetic Unit